Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Duarte

Showing results (291-300 of 303) with videos related to

Pageof 31
Sort By:
Blood Advances|August 17, 2021
Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implicationsMarta Lopes, Tiago L Duarte, Maria J Teles, et al.
Veterinary Journal (London, England : 1997)|March 15, 2024
Antimicrobial prophylaxis in companion animal surgery: A scoping review for European Network for Optimization of Antimicrobial Therapy (ENOVAT) guidelinesT M Sørensen, K Scahill, J Espinel Ruperez, et al.
Nature Metabolism|July 6, 2019
Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidinPei Jin Lim, Tiago L Duarte, João Arezes, et al.
Oncogene|March 26, 2014
Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signalsE T Costa, G F Barnabé, M Li, et al.
Nature Communications|September 3, 2017
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3Sant-Rayn Pasricha, Pei Jin Lim, Tiago L Duarte, et al.
Signal Transduction and Targeted Therapy|July 13, 2025
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerabilityDiego A Pereira-Martins, Isabel Weinhäuser, Emmanuel Griessinger, et al.
Blood|May 28, 2024
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemiaLuísa Corrêa de Araújo Koury, Haesook T Kim, Maria Soledad Undurraga, et al.
Med (New York, N.Y.)|March 5, 2021
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and InfectionJoe N Frost, Tiong Kit Tan, Munawar Abbas, et al.
Haematologica|October 31, 2024
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-<i>trans</i> retinoic acidWellington F Silva, Haesook T Kim, Maria S Undurraga, et al.
Rheumatology (Oxford, England)|May 22, 2023
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritisMarkus Bredemeier, Ângela L Duarte, Marcelo M Pinheiro, et al.
Pageof 31

Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
Blood Advances|August 17, 2021
Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implicationsMarta Lopes, Tiago L Duarte, Maria J Teles, et al.
Veterinary Journal (London, England : 1997)|March 15, 2024
Antimicrobial prophylaxis in companion animal surgery: A scoping review for European Network for Optimization of Antimicrobial Therapy (ENOVAT) guidelinesT M Sørensen, K Scahill, J Espinel Ruperez, et al.
Nature Metabolism|July 6, 2019
Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidinPei Jin Lim, Tiago L Duarte, João Arezes, et al.
Oncogene|March 26, 2014
Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signalsE T Costa, G F Barnabé, M Li, et al.
Nature Communications|September 3, 2017
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3Sant-Rayn Pasricha, Pei Jin Lim, Tiago L Duarte, et al.
Signal Transduction and Targeted Therapy|July 13, 2025
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerabilityDiego A Pereira-Martins, Isabel Weinhäuser, Emmanuel Griessinger, et al.
Blood|May 28, 2024
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemiaLuísa Corrêa de Araújo Koury, Haesook T Kim, Maria Soledad Undurraga, et al.
Med (New York, N.Y.)|March 5, 2021
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and InfectionJoe N Frost, Tiong Kit Tan, Munawar Abbas, et al.
Haematologica|October 31, 2024
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-<i>trans</i> retinoic acidWellington F Silva, Haesook T Kim, Maria S Undurraga, et al.
Rheumatology (Oxford, England)|May 22, 2023
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritisMarkus Bredemeier, Ângela L Duarte, Marcelo M Pinheiro, et al.
Pageof 31